Nitto Denko Corp (6988):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Nitto Denko Corp (6988) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9973
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Nitto Denko Corp (Nitto) is a manufacturer of diversified material, which produces electrical insulating material, electronics, industrial and functional products by harnessing its core technologies such as polymer synthesis, and adhesive and coating technologies. The company offers a broad spectrum of high value-added products, which includes optical films for liquid crystal displays, automotive materials and parts, gasket materials, materials for housing and construction, membrane products, surface protective films, and double sided tapes. Nitto caters to various industries, including transportation, house equipment, infrastructure, materials, electrical and medical. It owns and manages manufacturing plants, sales offices, and R&D centers across the world. Nitto is headquartered in Osaka, Japan.

Nitto Denko Corp (6988) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Nitto Denko Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Nitto Denko Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Nitto Denko Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Nitto Denko Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Nitto Denko Corp, Medical Devices Deals, 2012 to YTD 2018 9
Nitto Denko Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Nitto Denko Corp, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
Nitto Denko Avecia Acquires Assets of Irvine Pharma and Avrio Biopharma 11
Licensing Agreements 12
Bristol-Myers Squibb Enters into Licensing Agreement with Nitto Denko 12
Acquisition 13
Nitto Denko Avecia Completes Acquisition Of Girindus America For US$10 Million 13
Nitto Denko Acquires Altea Therapeutics 14
Apotex Acquires Aveva Drug Delivery Systems From Nitto Denko 15
Nitto Denko Corp – Key Competitors 16
Nitto Denko Corp – Key Employees 17
Nitto Denko Corp – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
Nitto Denko Corp, Pharmaceuticals & Healthcare, Key Facts, 2018 2
Nitto Denko Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Nitto Denko Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Nitto Denko Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Nitto Denko Corp, Deals By Therapy Area, 2012 to YTD 2018 8
Nitto Denko Corp, Medical Devices Deals, 2012 to YTD 2018 9
Nitto Denko Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Nitto Denko Avecia Acquires Assets of Irvine Pharma and Avrio Biopharma 11
Bristol-Myers Squibb Enters into Licensing Agreement with Nitto Denko 12
Nitto Denko Avecia Completes Acquisition Of Girindus America For US$10 Million 13
Nitto Denko Acquires Altea Therapeutics 14
Apotex Acquires Aveva Drug Delivery Systems From Nitto Denko 15
Nitto Denko Corp, Key Competitors 16
Nitto Denko Corp, Key Employees 17
Nitto Denko Corp, Other Locations 18
Nitto Denko Corp, Subsidiaries 19

List of Figures
Nitto Denko Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Nitto Denko Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Nitto Denko Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Nitto Denko Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Nitto Denko Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Nitto Denko Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Nitto Denko Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Nitto Denko Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Nitto Denko Corp, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Nitto Denko Corp (6988):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Zain Group (ZAIN):企業の財務・戦略的SWOT分析
    Zain Group (ZAIN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Birla Corporation Ltd:企業の戦略・SWOT・財務情報
    Birla Corporation Ltd - Strategy, SWOT and Corporate Finance Report Summary Birla Corporation Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Public Financial Holdings Ltd (626)
    Public Financial Holdings Ltd (626) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company
  • Fomento de Construcciones y Contratas SA (FCC):電力:M&Aディール及び事業提携情報
    Summary Fomento de Construcciones y Contratas SA (FCC) is a citizen services company. It provides services in environmental, water, and infrastructure development sectors. The company manages and treats domestic and industrial waste; provides integrated water management services; and designs, develo …
  • Thomas Cook (India) Limited:企業の戦略・SWOT・財務情報
    Thomas Cook (India) Limited - Strategy, SWOT and Corporate Finance Report Summary Thomas Cook (India) Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Kalpataru Power Transmission Ltd:企業の戦略・SWOT・財務情報
    Kalpataru Power Transmission Ltd - Strategy, SWOT and Corporate Finance Report Summary Kalpataru Power Transmission Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Gulf Island Fabrication Inc (GIFI):企業の財務・戦略的SWOT分析
    Gulf Island Fabrication Inc (GIFI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Krispy Kreme Doughnuts, Inc.:企業の戦略的SWOT分析
    Krispy Kreme Doughnuts, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Ingram Entertainment Inc.:戦略・SWOT・企業財務分析
    Ingram Entertainment Inc. - Strategy, SWOT and Corporate Finance Report Summary Ingram Entertainment Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Aquila Resources Ltd:企業の戦略・SWOT・財務情報
    Aquila Resources Ltd - Strategy, SWOT and Corporate Finance Report Summary Aquila Resources Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Almac Diagnostics Ltd:製品パイプライン分析
    Summary Almac Diagnostics Ltd (Almac Diagnostics), formerly ArraDx Ltd, a subsidiary of Almac Group Ltd, medical diagnostic company that discovers, develops and commercializes diagnostic tests including companion diagnostics. The company’s products pipeline includes ColDx, DDRD, AADx, prostate Dx, a …
  • Trex Company Inc (TREX):企業の財務・戦略的SWOT分析
    Trex Company Inc (TREX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Curis Inc (CRIS):製薬・医療:M&Aディール及び事業提携情報
    Summary Curis Inc (Curis) is a biotechnology company that focuses on developing and commercializing novel drug candidates for treating human cancers with substantial unmet medical need. It has three drug candidates in development, CUDC-907 for diffuse large B-cell lymphoma (DLBCL) and solid tumors; …
  • IBIDEN Co Ltd (4062):企業の財務・戦略的SWOT分析
    IBIDEN Co Ltd (4062) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Asatsu-DK Inc.:企業の戦略的SWOT分析
    Asatsu-DK Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Topcon Corp (7732):企業の財務・戦略的SWOT分析
    Topcon Corp (7732) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Ross Stores Inc:戦略・SWOT・企業財務分析
    Ross Stores Inc - Strategy, SWOT and Corporate Finance Report Summary Ross Stores Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • viDA Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary viDA Therapeutics Inc (viDA) is a biopharmaceutical company that discovers, develops and commercializes novel and targeted therapeutics for the treatment of autoimmune and age-related chronic inflammatory diseases. The company’s lead product candidate include VTI-1002, is in a topical formul …
  • NiSource Inc (NI):石油・ガス:M&Aディール及び事業提携情報
    Summary NiSource Inc (NiSource) is a regulated energy utility. The company distributes natural gas; and generates, transmits and distributes electricity. It produces electricity from coal, gas and hydro sources. NiSource operates electricity transmission systems and natural gas transmission pipeline …
  • National Railroad Passenger Corporation:企業の戦略・SWOT・財務情報
    National Railroad Passenger Corporation - Strategy, SWOT and Corporate Finance Report Summary National Railroad Passenger Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆